# Pharmaceutical regulation in Europe and its impact on corporate R&D

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pharmaceutical-regulation-in-europe-and-its-impact-on-corporate-r-and-amp-d/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stephan Eger,Jörg Mahlich |
| Citations | 39 |
| DOI | 10.1186/s13561-014-0023-5 |
| Fields | Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | gold |
| OA URL | https://healtheconomicsreview.biomedcentral.com/track/pdf/10.1186/s13561-014-0023-5 |
| OpenAlex ID | https://openalex.org/W2116103252 |
| PMID | 26208924 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Jörg Mahlich](https://scholariq.org/researchers/jorg-mahlich/)

## Paper primary topic

- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

## Paper topics

- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Innovation Policy and R&D](https://scholariq.org/topics/innovation-policy-and-r-and-d/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.